NIH-funded research Fellowship grant

Understanding how gut bacteria affect cell stress responses

Official title: Linking a prominent gut microbiome-derived metabolite to host proteostasis

Funded at Harvard Medical School · NIH-10889049 · Data updated 2026-11-12

This study is looking at how a molecule made by gut bacteria, called lithocholic acid, affects how our bodies handle stress at the cellular level, which could help us understand its role in liver health and diseases like metabolic disorders and cancer.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2023
Project endJuly 31, 2026
Funding year2024
Award (this year)$79,756
NIH project number5F32GM149112-02
Project IDNIH-10889049 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with metabolic disorders, neurodegenerative diseases, or cancers that may be influenced by cellular stress responses.

Less likely to help

Patients with conditions unrelated to cellular stress or those not affected by gut microbiome interactions may not benefit from this research.

What this research studies

This research investigates how a specific molecule produced by gut bacteria, known as lithocholic acid (LCA), influences the body's response to cellular stress. By examining how LCA activates a signaling pathway related to protein folding and cellular health, the study aims to uncover the mechanisms behind this interaction. The research employs various physiological models and advanced techniques to explore the effects of LCA on liver function and the broader implications for diseases linked to cellular stress, such as metabolic disorders and cancer.

Why it matters

Potential benefit: If successful, this research could lead to new insights into treating diseases related to cellular stress, potentially improving outcomes for patients with metabolic disorders and certain cancers.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiome metabolites in human health, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Maier, Nolan Kenji Kwaisun — Harvard Medical School
  • Study coordinator: Maier, Nolan Kenji Kwaisun

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.